137 related articles for article (PubMed ID: 26401103)
1. Lead-Induced Cell Cycle Arrest in Human Liver Carcinoma (HepG
Yedjou CG; Tchounwou PB
Met Ions Biol Med; 2011; 11():242-246. PubMed ID: 26401103
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2).
Tchounwou PB; Yedjou CG; Dorsey WC
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1071-9. PubMed ID: 14682389
[TBL] [Abstract][Full Text] [Related]
3. Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide.
Yedjou CG; Tchounwou PB
Mol Cell Biochem; 2009 Nov; 331(1-2):207-14. PubMed ID: 19444595
[TBL] [Abstract][Full Text] [Related]
4. N-Acetyl-cysteine Protection Against Lead-Induced Oxidative Stress and Genotoxicity in Human Liver Carcinoma (HepG
Yedjou CG; Waters D; Tchounwou PB
Met Ions Biol Med; 2008; 10():419-424. PubMed ID: 26549975
[TBL] [Abstract][Full Text] [Related]
5. Essential oil of lemon myrtle (Backhousia citriodora) induces S-phase cell cycle arrest and apoptosis in HepG2 cells.
Wang YF; Zheng Y; Cha YY; Feng Y; Dai SX; Zhao S; Chen H; Xu M
J Ethnopharmacol; 2023 Aug; 312():116493. PubMed ID: 37054823
[TBL] [Abstract][Full Text] [Related]
6. Potassium dichromate induced cytotoxicity, genotoxicity and oxidative stress in human liver carcinoma (HepG2) cells.
Patlolla AK; Barnes C; Hackett D; Tchounwou PB
Int J Environ Res Public Health; 2009 Feb; 6(2):643-53. PubMed ID: 19440407
[TBL] [Abstract][Full Text] [Related]
7. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-l-cysteine affords protection against lead-induced cytotoxicity and oxidative stress in human liver carcinoma (HepG2) cells.
Yedjou CG; Tchounwou PB
Int J Environ Res Public Health; 2007 Jun; 4(2):132-7. PubMed ID: 17617676
[TBL] [Abstract][Full Text] [Related]
9. CYP1a1, HSP70, P53, and c-fos expression in human liver carcinoma cells (HepG2) exposed to pentachlorophenol.
Dorsey WC; Tchounwou PB
Biomed Sci Instrum; 2003; 39():389-96. PubMed ID: 12724925
[TBL] [Abstract][Full Text] [Related]
10. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
11. OXIDATIVE STRESS IN HUMAN LEUKEMIA (HL-60), HUMAN LIVER CARCINOMA (HepG2), AND HUMAN (JURKAT-T) CELLS EXPOSED TO ARSENIC TRIOXIDE.
Yedjou CG; Tchounwou PB
Met Ions Biol Med; 2006; 9():298-303. PubMed ID: 26435679
[TBL] [Abstract][Full Text] [Related]
12. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
13. Lead-induced cytotoxicity and transcriptional activation of stress genes in human liver carcinoma (HepG2) cells.
Tchounwou PB; Yedjou CG; Foxx DN; Ishaque AB; Shen E
Mol Cell Biochem; 2004 Jan; 255(1-2):161-70. PubMed ID: 14971657
[TBL] [Abstract][Full Text] [Related]
14. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Tanaka T; Miyazawa K; Kitamura N
J Biochem; 2004 Nov; 136(5):701-9. PubMed ID: 15632311
[TBL] [Abstract][Full Text] [Related]
15. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
[TBL] [Abstract][Full Text] [Related]
16. Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex.
Zhang XH; Zou ZQ; Xu CW; Shen YZ; Li D
Mol Med Rep; 2011; 4(2):273-7. PubMed ID: 21468563
[TBL] [Abstract][Full Text] [Related]
17. HY253, a novel decahydrofluorene analog, induces apoptosis via intrinsic pathway and cell cycle arrest in liver cancer HepG2 cells.
Choi KW; Suh H; Jang S; Kim D; Lee CH
J Microbiol Biotechnol; 2015 Mar; 25(3):413-7. PubMed ID: 25674801
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
[TBL] [Abstract][Full Text] [Related]
19. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells.
Tian Z; Shen J; Moseman AP; Yang Q; Yang J; Xiao P; Wu E; Kohane IS
Int J Cancer; 2008 Jan; 122(1):31-8. PubMed ID: 17847033
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
Das SK; Hashimoto T; Kanazawa K
Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
